HOSPITAL UNIVERSITARIO RUBER
Saila
University of Pittsburgh School of Medicine
Pittsburgh, Estados UnidosUniversity of Pittsburgh School of Medicine-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2018
-
Nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic Breast cancer: Results from the tnAcity trial
Annals of Oncology, Vol. 29, Núm. 8, pp. 1763-1770